Q49. A pharmaceutical company facing a regulatory and techno…

Q49. A pharmaceutical company facing a regulatory and technological discontinuity sets up a separate exploratory unit while allowing legacy units to continue serving current markets. Which adaptation mode from Birkinshaw and colleagues does this most closely represent?

Q25. A knowledge-intensive firm wants to redesign itself so…

Q25. A knowledge-intensive firm wants to redesign itself so that: (1) small units remain entrepreneurial, (2) expertise travels across boundaries, (3) the organization keeps questioning old assumptions, and (4) the whole system stays aligned around a clear purpose. Which design package is most defensible from the assigned readings?